One Word, Many Medicines

Before you read: This guide is here to help you understand your own hormone care and ask better questions, not to replace your doctor, and not so you can adjust anything on your own. Read it, and bring it with you to your appointment.

Two things arrive on the same afternoon. A news story says progesterone raises the risk of breast cancer. A podcast on your feed says progesterone protects against it. You are taking something called progesterone, and you now have two answers and no way to choose between them.

Both stories are partly right. They are describing different medicines that share a name.

This article is about that name, where it came from, and how to tell which medicine the sentence in front of you is actually about.

What progesterone does when your body makes it

For roughly the first two weeks of a natural cycle, estrogen leads. It builds. The lining of the uterus thickens, breast tissue responds, bone is supported, and the tissues associated with fertility are stimulated toward readiness.

Around day twelve or thirteen, ovulation happens, and progesterone steps forward. Progesterone returns to the same tissue estrogen has been building and finishes the work. It matures the lining rather than growing it further. It improves the structure and the blood supply. It organizes breast tissue rather than simply stimulating it.

Progesterone also crosses into the brain, where the body converts it into a compound that acts on the system responsible for calm and sleep. This is one reason the second half of a healthy cycle can feel steadier than the first.

None of this is confusing inside your body. Your body has been running it without instruction since adolescence.

The confusion starts when a version of it is written on a prescription.

How the word got loose

In medicine, "progesterone" came to describe a job rather than a molecule.

The job is this: protect the lining of the uterus from being overstimulated by estrogen. Any compound that can do that job is allowed into the category. That is a useful shorthand for a prescriber and a poor one for a patient, because it groups together medicines that behave very differently once they are inside you.

There are four broad families.

Progesterone itself. The molecule your body already makes. On a prescription it may appear as micronized progesterone, and it comes in several forms.

Progesterone-derived synthetics. The original molecule with a chemical group added to it. Medroxyprogesterone acetate is the one most often discussed. The addition changes how it behaves.

Testosterone-derived synthetics. Built from a different parent molecule entirely. Norethindrone and levonorgestrel are in this family. They bind in ways progesterone does not.

Diuretic-derived synthetics. Drospirenone descends from a medication originally used for fluid and blood pressure, and it carries some of that behavior with it.

All four can protect the uterine lining. That is the one thing they share. Where a medicine comes from predicts how it behaves far better than the family name does.

What only the original can do

Your body has a pathway that converts progesterone into the compound that acts on the brain's calming system. That pathway needs progesterone as its raw material. The synthetic versions have been altered in ways that close the door, so the body cannot make that compound from them.

This is why some women describe progesterone as settling, and why the same conversion explains drowsiness for some and, for a smaller group, the opposite effect. That story has its own article later in this series.

Progesterone is also an important part of how breast tissue is organized. We can describe that mechanism honestly, and we will not go further than the evidence goes. There is laboratory work and there is a good mechanistic understanding. There is no trial in women showing that progesterone prevents or treats breast cancer. Anyone who tells you otherwise has crossed a line we will not cross.

The synthetics are not villains

There is a habit in some circles of describing synthetic progestins as uniformly harmful. That framing is not accurate and it does not help you.

There are real clinical situations where a synthetic is the correct choice. A lining that has become significantly overgrown is one of them. A woman who does not respond well to progesterone is another. A prescriber who understands why they are choosing a particular medicine, and can explain that reasoning to you, is practicing well regardless of which family the medicine comes from.

What you are owed is not a preferred molecule. It is the name of yours, the reason it was chosen, and what will be watched while you take it.

The study behind the headlines

In the early 2000s a large trial called the Women's Health Initiative reported that women taking a particular estrogen together with a particular synthetic progestin developed more breast cancer than women taking placebo. It was a serious trial and the finding was real.

What happened next caused decades of harm. The result was communicated as though it applied to all hormone therapy in all women. A generation of women stopped treatment, and many of them suffered for it.

The detail that got lost is the one that matters most here. The trial also had a group taking the estrogen alone, without the progestin. That group did not show the same increase. The signal appeared when the synthetic progestin was added.

Which means the finding is a finding about a specific combination, taken a specific way, by women whose average age was sixty-three. Progesterone itself was not in that trial at all.

The medicine you are on is what determines what that study says about you.

Six things a study has to match before it is about you

When someone tells you what the research shows, the fair questions are:

• Which medicine. The exact molecule, not the family name.
• How much. The amount used in the study.
• Taken how. Swallowed, through the skin, or another route.
• For how long. Months, or years.
• With which estrogen, if any was paired with it.
• In which women. Their ages, histories, and health.

Remove any one of those and a finding stops being evidence and becomes a slogan. You do not need to memorize the six. You need to remember that there are six, and that a headline usually mentions one.

Why the direct comparison was never run

No trial has directly compared progesterone against the synthetic progestin from that famous study for cancer or heart outcomes.

This is a fact about funding rather than a fact about biology. The synthetic was a branded product with a company behind it capable of financing a trial of fifteen thousand women. Progesterone is a molecule the body already makes, which means no company holds it and no company has a reason to pay for the research.

When two medicines have never been compared directly, it usually means nobody was willing to pay for the comparison. That is not the same as the question being asked and answered.

You deserve that research. It has not been done.

The half that is rarely mentioned

Being prescribed the right molecule is only part of the picture. How a medicine enters your body changes where it goes and how much arrives.

Progesterone in particular changes a great deal on its way through you depending on the route. A route that delivers strongly to one destination may deliver less to another. Some routes are designed so that very little shows up in the bloodstream, which means a low blood level can be the plan working rather than failing.

This has a practical consequence. Feeling an effect and a tissue receiving what it needs are two different things, and one does not confirm the other. Which route, and why that one, is a fair question about any prescription.

A related note on testing. A progesterone blood test measures progesterone. If you are taking a synthetic version, the test is looking for something you are not taking, and a low result tells you nothing about whether your medicine is working. Blood testing has its own articles later in this series, because the subject deserves more room than a paragraph.

Consent is what happens before the signature

You cannot agree to something you do not understand. Signing a form at an appointment is not consent. Consent is the understanding that the signature comes after.

Four questions belong to you, and asking them is not a challenge to anyone's expertise:

• What is the exact name of what I am taking?
• Which family does it belong to?
• Was the safety information about my medicine, taken my way?
• What would make this plan change?

You should also feel able to ask five days later, or five months later, when the question you did not think of in the room finally arrives. A good clinical relationship has that door left open.

Please do not act on this alone

Learning that these medicines differ is not a reason to stop, swap, or reduce anything on your own.

If you have a uterus and take systemic estrogen, protecting the lining is not optional. Changing from one of these medicines to another changes the molecule, the amount, the schedule, and often the route, all at the same time. That is a prescribing decision, made with someone who can monitor what happens next.

This article exists to give you a better conversation, not to give you a decision to make at your kitchen table.

What to carry

Progesterone and progestin were collapsed into one word for convenience, and that convenience has been costing women clarity for decades. Naming the molecule is not a technicality. It is the first honest act of consent.

When someone tells you what the research shows, ask which medicine, taken which way, by which women.

If the answer is not yours, the finding is not yours either.

This article is part of HRT for Women Throughout Life, Part Three: Progesterone Literacy, from Protea Institute. It is education, not medical advice, and it is not a substitute for care from a clinician who knows your history.